- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0102707

Klnts Pharmaceuticals Private Limited
About Klnts Pharmaceuticals Private Limited
Data last updated:
Klnts Pharmaceuticals Private Limited is a private limited company based in Sriperumbudur, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2021PTC147041. Its GSTIN is 10AAJCK0867F1ZT (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Kumar (Managing Director) and Nirmal Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sriperumbudur, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.57 Lakh, a growth of 135% compared to the previous year. For the same year it recorded a net profit of ₹22,202 (net margin 0.8%) and EBITDA of ₹30,002 (EBITDA margin 1%).
Klnts Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0102707). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Klnts Pharmaceuticals
Contact details
Klnts Pharmaceuticals Private Limited's registered office is in Sriperumbudur, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressOsion Chlorophyll Block No 5, 13 Floor Devi Parasakthi Nagar Karambakkam Channai, Sriperumbudur, Tamil Nadu, India – 600116
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Klnts Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Klnts Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Klnts Pharmaceuticals Private Limited, buy the company report.
Financials of Klnts Pharmaceuticals Private Limited
FY 2025 filings availableKlnts Pharmaceuticals Private Limited reported revenue of ₹29.57 Lakh (up 135% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 135% in the latest year. EBITDA rose 200% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹30,002 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹22,202 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1% | ||
| Net Profit Margin | 0.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Klnts Pharmaceuticals Private Limited, buy the company report.
Board of directors of Klnts Pharmaceuticals Private Limited
Klnts Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Kumar Mishra | Director | 13 Oct 2021 | 5 Years 0 Months | Current |
| Santosh Kumar | Managing Director | 13 Oct 2021 | 5 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Klnts Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Klnts Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Klnts Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 23, 2024.
GST
Klnts Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAJCK0867F1ZT | Bihar | Active | 29 Dec 2021 |
To see the full GST registrations and return filing status of Klnts Pharmaceuticals Private Limited, buy the company report.
Recent activity
Klnts Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nirmal Kumar Mishra was appointed as Director on 13 Oct 2021.
Frequently asked questions
Klnts Pharmaceuticals is an active private limited company based in Sriperumbudur, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 October 2021 (5+ years old) and is registered under CIN U24230TN2021PTC147041.
Klnts Pharmaceuticals has 2 current directors:
- Santosh Kumar - Managing Director
- Nirmal Kumar Mishra - Director
The latest financial statements of Klnts Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Klnts Pharmaceuticals is 10AAJCK0867F1ZT, registered in Bihar.
The CIN (Corporate Identification Number) of Klnts Pharmaceuticals is U24230TN2021PTC147041. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Klnts Pharmaceuticals was incorporated on 13 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Nirmal Kumar Mishra was appointed as Director on 13 Oct 2021. Santosh Kumar was appointed as Managing Director on 13 Oct 2021.
Yes, Klnts Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0102707).
The registered office of Klnts Pharmaceuticals is at Osion Chlorophyll Block No 5, 13 Floor Devi Parasakthi Nagar Karambakkam Channai, Sriperumbudur, Tamil Nadu, India – 600116.
Klnts Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

